Skip to content
10-K

Annual Report

Kestra Medical Technologies, Ltd. KMTS

0000950170-25-096609

← back to feed
Filed
Jul 17, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jul 17, 2025 51.35M sh
Shares Diluted FY 2025 · Apr 30, 2025 24.58M sh
Shares Diluted FY 2025 · Apr 30, 2024 19.89M sh
Capex FY 2025 · Apr 30, 2025 $22.94M
Capex FY 2025 · Apr 30, 2024 $12.23M
Operating Cash Flow FY 2025 · Apr 30, 2025 −$77.61M
Operating Cash Flow FY 2025 · Apr 30, 2024 −$72.24M
Long Term Debt FY 2025 · Apr 30, 2025 $41.1M
Long Term Debt FY 2025 · Apr 30, 2024 $42.54M
Cash And Equivalents FY 2025 · Apr 30, 2025 $237.6M
Cash And Equivalents FY 2025 · Apr 30, 2024 $8.25M
Stockholders Equity FY 2025 · Apr 30, 2025 $205.41M
Stockholders Equity FY 2025 · Apr 30, 2024 −$209.38M
Stockholders Equity FY 2025 · Apr 30, 2023 −$117.58M
Current Liabilities FY 2025 · Apr 30, 2025 $37.98M
Current Liabilities FY 2025 · Apr 30, 2024 $32.97M
Total Liabilities FY 2025 · Apr 30, 2025 $90.34M
Total Liabilities FY 2025 · Apr 30, 2024 $78.22M
Current Assets FY 2025 · Apr 30, 2025 $255.33M
Current Assets FY 2025 · Apr 30, 2024 $14.91M
Total Assets FY 2025 · Apr 30, 2025 $295.74M
Total Assets FY 2025 · Apr 30, 2024 $45.95M
Eps Diluted FY 2025 · Apr 30, 2025 −$5.13
Eps Diluted FY 2025 · Apr 30, 2024 −$5.07
Eps Basic FY 2025 · Apr 30, 2025 −$5.13
Eps Basic FY 2025 · Apr 30, 2024 −$5.07
Sga Expense FY 2025 · Apr 30, 2025 $114.94M
Sga Expense FY 2025 · Apr 30, 2024 $69.94M
Rd Expense FY 2025 · Apr 30, 2025 $15.65M
Rd Expense FY 2025 · Apr 30, 2024 $15.49M
Net Income FY 2025 · Apr 30, 2025 −$113.81M
Net Income FY 2025 · Apr 30, 2024 −$94.12M
Operating Income FY 2025 · Apr 30, 2025 −$106.38M
Operating Income FY 2025 · Apr 30, 2024 −$85.06M
Gross Profit FY 2025 · Apr 30, 2025 $24.21M
Gross Profit FY 2025 · Apr 30, 2024 $362K
Cost Of Revenue FY 2025 · Apr 30, 2025 $35.61M
Cost Of Revenue FY 2025 · Apr 30, 2024 $27.45M
Revenue FY 2025 · Apr 30, 2025 $59.82M
Revenue FY 2025 · Apr 30, 2024 $27.81M